Who owns SUTRO BIOPHARMA INC?
- Ticker: STRO
- CUSIP Number: 869367201
Tip: Access positions for across all investors
Analyze quarterly positions in Sutro Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Sutro Biopharma stock
Who bought or sold SUTRO BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 1.3M | $31M | 100% | Mar 2026 |
|
| Samsara BioCapital | 1.1M | $27M | 420% | Mar 2026 |
|
| Kynam Capital Management | 873k | $22M | 82% | Mar 2026 |
|
| OrbiMed Advisors | 801k | $20M | 100% | Mar 2026 |
|
| Affinity Asset Advisors | 748k | $8.7M | 100% | Dec 2025 |
|
| Vanguard Capital Management | 720k | $18M | 100% | Mar 2026 |
|
| RA Capital Management | 715k | $18M | 100% | Mar 2026 |
|
| Perceptive Advisors | 715k | $18M | 100% | Mar 2026 |
|
| Point72 Asset Management | 692k | $17M | 286% | Mar 2026 |
|
| ADAR1 Capital Management | 524k | $13M | 682% | Mar 2026 |
|
| Balyasny Asset Management | 466k | $12M | 102% | Mar 2026 |
|
| Woodline Partners | 457k | $11M | 100% | Mar 2026 |
|
| UBS Group | 393k | $9.8M | 4892% | Mar 2026 |
|
| Vanguard Group | 376k | $4.3M | 100% | Dec 2025 |
|
| Acadian Asset Management | 336k | $8.4M | -1% | Mar 2026 |
|
| Velan Capital Investment Management | 312k | $3.6M | 100% | Dec 2025 |
|
| Longwood Capital Partners | 269k | $6.7M | 299% | Mar 2026 |
|
| BlackRock | 233k | $5.8M | 98% | Mar 2026 |
|
| KVP Capital Advisors | 227k | $5.6M | 100% | Mar 2026 |
|
| Millennium Management | 210k | $5.2M | -50% | Mar 2026 |
|
| Adage Capital Partners GP | 200k | $2.3M | 100% | Dec 2025 |
|
| Eversept Partners | 194k | $2.2M | 100% | Dec 2025 |
|
| Opaleye Management | 191k | $4.7M | 0% | Mar 2026 |
|
| Geode Capital Management | 171k | $4.3M | 104% | Mar 2026 |
|
| Citadel Advisors | 142k | $3.5M | 344% | Mar 2026 |
|
| Renaissance Technologies | 123k | $1.4M | 100% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 95k | $2.4M | 100% | Mar 2026 |
|
| Marshall Wace | 86k | $991k | 100% | Dec 2025 |
|
| Burkehill Global Management | 72k | $1.8M | 100% | Mar 2026 |
|
| Two Sigma Investments | 65k | $1.6M | 40% | Mar 2026 |
|
| Fisher Investments | 35k | $879k | 0% | Mar 2026 |
|
| Trexquant Investment | 34k | $856k | 100% | Mar 2026 |
|
| State Street Corporation | 34k | $397k | 100% | Dec 2025 |
|
| Jane Street | 28k | $692k | 21% | Mar 2026 |
|
| Goldman Sachs Group | 27k | $677k | 74% | Mar 2026 |
|
| GSA Capital Partners | 26k | $643k | -71% | Mar 2026 |
|
| Stempoint Capital | 23k | $580k | 100% | Mar 2026 |
|
| Bank of America Corporation | 19k | $470k | 100% | Mar 2026 |
|
| Citigroup | 19k | $469k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 19k | $468k | 100% | Mar 2026 |
|
| Invesco | 17k | $428k | 1% | Mar 2026 |
|
| Rbf Capital | 15k | $380k | 0% | Mar 2026 |
|
| Hudson Bay Capital Management | 15k | $368k | 100% | Mar 2026 |
|
| Northern Trust | 14k | $166k | 100% | Dec 2025 |
|
| Sigma Planning | 13k | $312k | 100% | Mar 2026 |
|
| Morgan Stanley | 11k | $262k | -34% | Mar 2026 |
|
| OMERS Administration Corporation | 8.7k | $217k | -21% | Mar 2026 |
|
| AQR Capital Management | 8.6k | $215k | -52% | Mar 2026 |
|
| Persistent Asset Partners | 7.4k | $185k | 100% | Mar 2026 |
|
| State of Tennessee, Treasury Department | 7.4k | $184k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 7.2k | $179k | 100% | Mar 2026 |
|
| CWM | 1.5k | $17k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 1.3k | $16k | 100% | Dec 2025 |
|
| FMR | 1.1k | $13k | 100% | Dec 2025 |
|
| FNY Investment Advisers | 1.0k | $24k | 0% | Mar 2026 |
|
| Owl Creek Wealth Partners | 491.00 | $12k | 100% | Mar 2026 |
|
| UMA Financial Services | 182.00 | $4.5k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 111.00 | $2.8k | 0% | Mar 2026 |
|
| Efficient Wealth Management | 72.00 | $1.0k | 0% | Mar 2026 |
|
| Pnc Financial Services | 62.00 | $1.5k | 0% | Mar 2026 |
|
| NISA Investment Advisors | 44.00 | $1.1k | 0% | Mar 2026 |
|
| SRS Capital Advisors | 41.00 | $75.001300 | 1267% | Mar 2026 |
|
| HighMark Wealth Management | 23.00 | $572.000800 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 12.00 | $0 | 100% | Mar 2026 |
|
| Brian McDonald | 3.00 | $35.000100 | 100% | Dec 2025 |
|
| Fifth Third Bancorp | 2.00 | $50.000000 | 100% | Mar 2026 |
|
Who sold out of Sutro Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vestal Point Capital | Dec 2025 | 243k | $2.8M |
| Tang Capital Management | Dec 2025 | 140k | $1.6M |
| None | Dec 2025 | 24k | $281k |
| Two Sigma Advisers | Dec 2025 | 18k | $203k |
| Wells Fargo & Company | Dec 2025 | 100.00 | $1.2k |
| Group One Trading | Dec 2025 | 2.00 | $23.000000 |